Literature DB >> 12225003

Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern.

Gloria Vergara, Juan Francisco Silvestre, Isabel Betlloch, Paloma Vela, María Pilar Albares, José Carlos Pascual.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12225003     DOI： 10.1001/archderm.138.9.1258

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

1.  Psoriasis onset during infliximab treatment: description of two cases.

Authors:  Alessandro Volpe; Paola Caramaschi; Antonio Carletto; Sara Pieropan; Lisa Maria Bambara; Domenico Biasi
Journal:  Rheumatol Int       Date:  2006-10       Impact factor: 2.631

2.  [Delayed-type cutaneous drug reactions. Pathogenesis, clinical features and histology].

Authors:  M Ziemer
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

3.  Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.

Authors:  Marcel Flendrie; Wynand H P M Vissers; Marjonne C W Creemers; Elke M G J de Jong; Peter C M van de Kerkhof; Piet L C M van Riel
Journal:  Arthritis Res Ther       Date:  2005-04-04       Impact factor: 5.156

4.  Immediate-type infliximab infusion reaction presenting as purpura.

Authors:  Laura Soong; Bahman Sotoodian; Alain Brassard
Journal:  JAAD Case Rep       Date:  2018-06-20

5.  Lichenoid Reactions in Association with Tumor Necrosis Factor Alpha Inhibitors: A Review of the Literature and Addition of a Fourth Lichenoid Reaction.

Authors:  Morgan McCarty; Amy Basile; Brooke Bair; David Fivenson
Journal:  J Clin Aesthet Dermatol       Date:  2015-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.